Ticker Launch
Sign inTry it free

SPAC · Merger completed

Helix Acquisition Corp.

Business combination with MoonLake Immunotherapeutics AG

Helix Acquisition Corp. is a blank-check company (SPAC) that raised $100M in its initial public offering on Oct 21, 2020, listing on Nasdaq. It completed its business combination with MoonLake Immunotherapeutics AG on Apr 5, 2022; the combined company is MoonLake Immunotherapeutics (MLTX). White & Case advised the SPAC and Kirkland & Ellis advised the underwriters on the IPO.

MoonLake Immunotherapeutics AG, founded in 2021, is a clinical-stage biotechnology company advancing sonelokimab, a tri-specific Nanobody that inhibits IL-17A/F. It targets inflammatory skin and joint diseases, with dermatology and rheumatology indications, initially psoriasis.

Status
Merger completed
IPO date
Oct 21, 2020
IPO size
$100M
IPO exchange
Nasdaq
Target
MoonLake Immunotherapeutics AG
Announced
Oct 4, 2021
Closed
Apr 5, 2022
Combined company
MoonLake Immunotherapeutics (MLTX)
SPAC counsel (IPO)
White & Case and Maples and Calder
Underwriters' counsel (IPO)
Kirkland & Ellis

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022